Auranofin Oral Capsule

Brand(s)
Ridaura
Category(s)
prescription
SPL Type(s)
Human Prescription
Master SPL
Prometheus Laboratories Inc. (2011-12-15)
Oldest Current Product
1985-04-24
License(s)
NDA
RxNORM
ORAL CAPSULE\AURANOFIN
FDAOB
ORAL\CAPSULE\AURANOFIN
SPL Active
ORAL\CAPSULE\AURANOFIN
SPL Moiety
ORAL\CAPSULE\AURANOFIN

product(s) by strength(s)

auranofin 3 mg oral capsule

original product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1654830093RidauraNDAPrometheus Laboratories Inc.1985-04-24AURANOFINORALCAPSULENDA01868905c34ddf-a0f7-4267-83f5-d02be3defc37

application(s)

#idtitleapplicantapprovedapproved drug
1NDA018689RIDAURAPROMETHEUS LABORATORIES INC1985-05-24NDA018689_001

application drug(s)

#idcategory/deprecatedingredient strength(s)routedose formrldapprovedapplication
1NDA018689_001RXAURANOFIN (3MG)ORALCAPSULETrue1985-05-24RIDAURA

spl(s)

#idtitlecategorytypelabelerlabeler actlast updateversionproduct(s)
105c34ddf-a0f7-4267-83f5-d02be3defc37 (view SPL)PRESCRIBING INFORMATION RIDAURA Auranofin CapsulesprescriptionHuman PrescriptionPrometheus Laboratories Inc.ANALYSIS, MANUFACTURE2011-12-153654830093

Data from: FDAOB, FDAPB, LOINC, MTHSPL, NDFRT, NCIT, RxNORM, UNII